Literature DB >> 18558299

Hypoalbuminemia and not hyperhomocysteinemia as a risk factor for dementia in hemodialysis patients.

Ying-Chih Huang1, Ya-Wen Kuo, Tsong-Hai Lee, Meng Lee, Ming-Chang Hsiao, Chia-Lian Wang, Jiann-Der Lee.   

Abstract

BACKGROUND: The most common causes of morbidity and mortality in uremic patients are cardiovascular disease and central nervous system dysfunction. However, the exact causes of dementia in uremic patients remain unclear. This study attempted to determine which risk factors are associated with dementia in hemodialysis patients.
METHODS: In total, 147 chronic uremic patients receiving regular hemodialysis treatment were recruited. Data for risk factors regarding cardiovascular disease and dementia, such as hypertension, diabetes mellitus, smoking, age, illiteracy, serum levels of albumin, cholesterol, triglycerides, and homocysteine, and liver function, were recorded. The Mini-Mental Status examination was used to assess mental function, and the Hachinski ischemic scale was applied to differentiate among dementia types. The diagnosis of dementia was based on criteria from the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition.
RESULTS: Twenty-six patients were diagnosed as manifesting dementia. Of all patients with dementia, 21 had a Hachinski score of 0 to 4, and 5 had a score of 7 to 10. In a multiple logistic regression analysis, low serum albumin and illiteracy were significantly associated with dementia. However, no difference existed between the two groups in terms of homocysteine levels.
CONCLUSIONS: This study demonstrated that uremic patients were prone to nonvascular dementia. We conclude that hypoalbuminemia and not hyperhomocysteinemia is a risk factor for dementia in hemodialysis patients.

Entities:  

Mesh:

Year:  2008        PMID: 18558299     DOI: 10.1053/j.jrn.2007.12.003

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  3 in total

1.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

2.  Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease.

Authors:  Shujun Sun; Yiyong Wen; Yandeng Li
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

Review 3.  Biomarkers for stroke.

Authors:  Suk Jae Kim; Gyeong Joon Moon; Oh Young Bang
Journal:  J Stroke       Date:  2013-01-31       Impact factor: 6.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.